Literature DB >> 17047154

Identification of a novel chromosome region, 13q21.33-q22.2, for susceptibility genes in familial chronic lymphocytic leukemia.

David Ng1, Ousmane Toure, Ming-Hui Wei, Diane C Arthur, Fatima Abbasi, Laura Fontaine, Gerald E Marti, Joseph F Fraumeni, Lynn R Goldin, Neil Caporaso, Jorge R Toro.   

Abstract

Chronic lymphocytic leukemia (CLL) is the most prevalent form of leukemia in adults in western countries. A genome scan of CLL-prone families revealed a lod score of one in band 13q22.1. To investigate this finding, we selected 6 CLL families consisting of 63 individuals (CLL affected, n=19; unaffected, n=44) for fine mapping of a 23-megabase region in 13q14.2-q22.2. Interphase fluorescence in situ hybridization (FISH) revealed 13q14 deletion in 85% (11/13) of CLL patients. Four CLL families shared a 3.68-Mb minimal region in 13q21.33-q22.2. Two asymptomatic siblings who shared the 13q21.33-q22.2 at-risk haplotype exhibited CD5+ monoclonal B-cell lymphocytosis (MBL) on flow cytometry. One of these individuals also had a 13q14 deletion by FISH. These 2 individuals with MBL shared the at-risk haplotype with their CLL-affected relatives, providing further evidence of the relationship between CLL and MBL, as well as of the biologic significance of this novel region. Using direct DNA sequencing analysis, we screened 13 genes for mutations, but no frameshift or nonsense mutations were detected. Our studies revealed that 11 of the 13 genes in the candidate region were expressed in immune tissues, supporting their functional relevance in investigations of familial CLL. In conclusion, we identified a novel candidate region that may predispose to familial CLL.

Entities:  

Mesh:

Year:  2006        PMID: 17047154     DOI: 10.1182/blood-2006-03-011825

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas.

Authors:  Lynn R Goldin; Ola Landgren; Gerald E Marti; Neil E Caporaso
Journal:  European J Clin Med Oncol       Date:  2010-02

Review 2.  Familial chronic lymphocytic leukemia.

Authors:  Lynn R Goldin; Susan L Slager; Neil E Caporaso
Journal:  Curr Opin Hematol       Date:  2010-07       Impact factor: 3.284

3.  Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.

Authors:  Elizabeth S Raveche; Erica Salerno; Brian J Scaglione; Vijaya Manohar; Fatima Abbasi; Yi-Chu Lin; Torgny Fredrickson; Pablo Landgraf; Sumant Ramachandra; Konrad Huppi; Jorge R Toro; Vincent E Zenger; Robert A Metcalf; Gerald E Marti
Journal:  Blood       Date:  2007-03-09       Impact factor: 22.113

Review 4.  Familial leukemias.

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2015-02

Review 5.  Familial chronic lymphocytic leukemia: what does it mean to me?

Authors:  Susan L Slager; Neil E Kay
Journal:  Clin Lymphoma Myeloma       Date:  2009

6.  Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future.

Authors:  Jennifer R Brown
Journal:  Ther Adv Hematol       Date:  2013-08

Review 7.  Genomic approaches to chronic lymphocytic leukemia.

Authors:  Ma Reina Improgo; Jennifer R Brown
Journal:  Hematol Oncol Clin North Am       Date:  2013-04       Impact factor: 3.722

8.  An integrated approach to inferring gene-disease associations in humans.

Authors:  Predrag Radivojac; Kang Peng; Wyatt T Clark; Brandon J Peters; Amrita Mohan; Sean M Boyle; Sean D Mooney
Journal:  Proteins       Date:  2008-08-15

9.  Chronic lymphocytic leukaemia: clinical-aetiological findings in 66 patients and their families.

Authors:  Walter Weber; Patrick F Maurer; Jacqueline Estoppey; Marcel Zwahlen
Journal:  Hered Cancer Clin Pract       Date:  2007-12-15       Impact factor: 2.857

10.  Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis.

Authors:  M C Lanasa; S D Allgood; A D Volkheimer; J P Gockerman; J F Whitesides; B K Goodman; J O Moore; J B Weinberg; M C Levesque
Journal:  Leukemia       Date:  2009-10-15       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.